These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36617941)

  • 1. Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation,
    Bimoussa A; Fawzi M; Oubella A; Ejaz SA; Sajjad Bilal M; Labd Taha M; Auhmani A; Morjani H; Robert A; Riahi A; Ait Itto MY
    J Biomol Struct Dyn; 2023; 41(21):11987-11999. PubMed ID: 36617941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studies.
    Oubella A; El Mansouri AE; Fawzi M; Bimoussa A; Laamari Y; Auhmani A; Morjani H; Robert A; Riahi A; Youssef Ait Itto M
    Bioorg Chem; 2021 Oct; 115():105184. PubMed ID: 34333421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, anticancer activity and molecular modeling study of novel substituted triazole linked tetrafluoronaphthalene hybrid derivatives.
    Erdoğan M; Comert Onder F
    J Biomol Struct Dyn; 2024 Nov; 42(18):9767-9786. PubMed ID: 37676264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiazolidinone-linked-1,2,3-triazoles with (R)-Carvone as new potential anticancer agents.
    Oubella A; Alossaimi MA; Riadi Y; Bhat MA; Bakheit AH; Taha ML; Auhmani A; Morjani H; Geesi MH; Ait Itto MY
    Future Med Chem; 2024; 16(14):1449-1464. PubMed ID: 39190475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
    Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
    Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical profiling, cytotoxic activities through apoptosis induction in human fibrosarcoma and carcinoma cells, and molecular docking of some 1,2,3-triazole-isoxazoline hybrids using the eugenol as a precursors.
    Oubella A; Taia A; Byadi S; Ait Lahcen M; Bimoussa A; Essaber M; Podlipnik C; Morjani H; Ait Itto MY; Aatif A
    J Biomol Struct Dyn; 2023 Apr; 41(7):2759-2771. PubMed ID: 35174765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel (
    Riadi Y; Afzal O; Kumar S; Varadharajan V; Geesi MH
    J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38523573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives.
    Ghanaat J; Khalilzadeh MA; Zareyee D
    Mol Divers; 2021 Feb; 25(1):223-232. PubMed ID: 32067134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis,
    Sridhar Goud N; Pooladanda V; Muni Chandra K; Lakshmi Soukya PS; Alvala R; Kumar P; Nagaraj C; Dawn Bharath R; Qureshi IA; Godugu C; Alvala M
    Bioorg Chem; 2020 Sep; 102():104125. PubMed ID: 32738568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives.
    Duan M; Mahal A; Alkouri A; Wang C; Zhang Z; Ren J; Obaidullah AJ
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. meta-Ureidophenoxy-1,2,3-triazole hybrid as a novel scaffold for promising HepG2 hepatocellular carcinoma inhibitors: Synthesis, biological evaluation and molecular docking studies.
    Limpachayaporn P; Nuchpun S; Sirirak J; Charoensuksai P; Wongprayoon P; Chuaypen N; Tangkijvanich P; Suksamrarn A
    Bioorg Med Chem; 2022 Nov; 74():117048. PubMed ID: 36270111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
    Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
    Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking Investigations.
    Al-Blewi F; Shaikh SA; Naqvi A; Aljohani F; Aouad MR; Ihmaid S; Rezki N
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and apoptotic effects of some (R)-carvone-isoxazoline derivatives on human fibrosarcoma and carcinoma cells: experimental evaluation for cytotoxicity, molecular docking and molecular dynamics studies.
    Oubella A; Bimoussa A; Byadi S; Laamari Y; Fawzi M; N'ait Ousidi A; Oblak D; Auhmani A; Riahi A; Morjani H; Ait Itto MY
    J Biomol Struct Dyn; 2023 Mar; 41(5):1930-1943. PubMed ID: 35014592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 1,3,4-thiadiazoles derivatives: synthesis, antiproliferative activity, molecular docking and molecular dynamics.
    Bimoussa A; Oubella A; Bamou FZ; Khdar ZA; Fawzi M; Laamari Y; Ait Itto MY; Morjani H; Auhmani A
    Future Med Chem; 2022 Jun; 14(12):881-897. PubMed ID: 35670219
    [No Abstract]   [Full Text] [Related]  

  • 18. Rational Design and Synthesis of Isatin-Chalcone Hybrids Integrated with 1H-1,2,3-Triazole: Anti-Proliferative Profiling and Molecular Docking Insights.
    Swati ; Raza A; Chowdhary S; Anand A; Shaveta ; Sharma AK; Kumar K; Kumar V
    ChemMedChem; 2024 Jul; 19(14):e202400015. PubMed ID: 38638026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
    Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
    Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Hybrid Design, Synthesis, In Vitro Cytotoxicity, In Silico ADME and Molecular Docking Studies of New Benzoate Ester-Linked Arylsulfonyl Hydrazones.
    Ergan E; Çakmak R; Başaran E; Mali SN; Akkoc S; Annadurai S
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39124882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.